Literature DB >> 22551459

HER2 amplification status in gastric and gastro-oesophageal junction cancer in routine clinical practice: which sample should be used?

Giuseppe Perrone, Michelina Amato, Marcella Callea, Carla Rabitti, Daniela Righi, Pierfilippo Crucitti, Roberto Coppola, Andrea Onetti Muda.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22551459     DOI: 10.1111/j.1365-2559.2012.04251.x

Source DB:  PubMed          Journal:  Histopathology        ISSN: 0309-0167            Impact factor:   5.087


× No keyword cloud information.
  2 in total

1.  HER2 in gastric cancer: comparative analysis of three different antibodies using whole-tissue sections and tissue microarrays.

Authors:  Lucas Faria Abrahão-Machado; Alexandre Andrade dos Anjos Jácome; Durval Renato Wohnrath; José Sebastião dos Santos; Estela Cristina Carneseca; José Humberto Tavares Guerreiro Fregnani; Cristovam Scapulatempo-Neto
Journal:  World J Gastroenterol       Date:  2013-10-14       Impact factor: 5.742

2.  HER2 Status in Gastric Cancer: Comparison between Primary and Distant Metastatic Disease.

Authors:  Michelina Amato; Giuseppe Perrone; Daniela Righi; Claudio Pellegrini; Carla Rabitti; Francesco Di Matteo; Pierfilippo Crucitti; Damiano Caputo; Roberto Coppola; Giuseppe Tonini; Daniele Santini; Andrea Onetti Muda
Journal:  Pathol Oncol Res       Date:  2016-06-30       Impact factor: 3.201

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.